Samir Ounzain News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HAYA Therapeutics, SA: HAYA Therapeutics Adds World-Leading Cardiologist and Dark Genome Pioneer to Advisory Boards

Ahmad Masri, Director of the Hypertrophic Cardiomyopathy Center at Oregon Health Science University, joins Clinical Advisory Board Cedric Feschotte, Professor, Department of Molecular Biology and

San diegoUnited statesDennis riedlTim ingersollPierre marie curieAhmad masriChristopher millerSamir ounzainErick schelbertCedric feschotteSudhir agrawalJohn rinnKnight cardiovascular instituteSchool of medicineDivision of cardiovascular medicineOregon health science university knight cardiovascular institute

HAYA Therapeutics Announces Funding from Swiss Innovation Agency Supporting Research Collaborations for Long Non-Coding RNA Therapies

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesSan diegoTim ingersollRobert riebenSamir ounzainUniversity hospital of bernLausanne university hospitalUniversity of bernLausanne university hospital centreSwiss innovation agencyUniversity hospitalLausanne universityBiomedical researchDaniel blessingInselspital bernSwiss innovation

HAYA Therapeutics Establishes U S Location

HAYA closes US$5M seed extension led by Humboldt Fund to advance the development of its anti-fibrotic lead program targeting Wisper, a cardiac long non-coding RNA HAYA Therapeutics, SA, a company

Switzerland generalSan diegoUnited statesKostenloser wertpapierhandelSebastian bernalesMichelle linnViva bioinnovatorSchroder adveqJens ecksteinSamir ounzainHumboldt fundBioscribe incApollo health venturesPartner at humboldt fundPartner at apollo health venturesJohnson innovation

RNA Therapeutics 2022

SMi Group’s 13th Annual Conference:RNA Therapeutics 20229th – 10th February 2022London, UKwww.therapeutics-rna.com/pharmiweb    Sponsored by: BIA Separations & eTheRNA ImmunotherapiesBolstering the latest advances and opportunities in RNA-based medicine The RNA therapeutics indust.

United kingdomCity ofPunit sethJimmy weteringsMiescher pharmaSteve pascoloSamir ounzainDavid loweNagy habibThomas thumMartin akermanHeinrich haasSmi groupResearch development directors managers scientistsImperial college londonHeads of clinical development

HAYA Therapeutics Completes CHF 18 Million Seed Financing To Advance Anti-fibrotic Therapies Targeting Long Non-coding RNAs

HAYA Therapeutics Completes CHF 18 Million Seed Financing To Advance Anti-fibrotic Therapies Targeting Long Non-coding RNAs
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSwitzerland generalRobert williamsonBenjamin kreitmanViva bioinnovatorSchroder adveqJens ecksteinSamir ounzainLausanne university hospitalBiotheryx incApollo health venturesPartner at apollo health venturesBroadview venturesExecutive chairManaging partnerDaniel blessing